Alit Stark-Inbar, PhD, Chief Scientific Officer of Theranica, writes about migraine prevention beyond lifestyle changes, highlighting the role of neuromodulation and other evidence-based treatments in long-term management.
Alit Stark-Inbar, PhD
Advertisement
Corporate vice president of medical information and research at Theranica.
Articles by Alit Stark-Inbar, PhD
The corporate vice president of medical information and research at Theranica discussed long-term findings presented at AHS 2025 covering the company’s Nerivio remote electrical neuromodulation device for patients with migraine. [WATCH TIME: 5 minutes]
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Clene Submits NDA Seeking Accelerated Approval for ALS Drug
2
Decade of OPERA Data Supports Early Ocrelizumab Treatment Initiation in Relapsing Multiple Sclerosis
3
First-in-Human Trial Begins for an Antisense Oligonucleotide in KCNT1-Related Epilepsy
4
RGX-202 Meets Primary End Point in Phase 3 Duchenne Trial
5